1-3 of 3
David Calverley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase III Randomized Trial for Frail Newly Diagnosed Multiple Myeloma Patients Comparing Bortezomib- Lenalidomide-Dexamethasone (VRd-Lite followed by Len maintenance) with Daratumumab-Lenalidomide- Dexamethasone (DRd followed by Len+/- Dara Maintenance): SWOG S2209

Sikander Ailawadhi, Antje Hoering, J Christine Ye, Brea Lipe, Thomas R. Chauncey, Krisstina Gowin, David Calverley, Sarah A. Holstein, Erica L. Campagnaro, Adam Rosenthal, Jack Aiello, Saad Z. Usmani, Vincent Rajkumar, Robert Z. Orlowski
Journal: Blood
Blood (2024) 144 (Supplement 1): 3381.3.
https://doi.org/10.1182/blood-2024-209626
Published: 2024
Journal Articles

Application of a Validated Predictive Model for Venous Thromboembolism in Cancer to Patients with Multiple Myeloma

Natasha Catherine Edwin, MD, Jesse Keller, MD, Suhong Luo, MS, Kenneth R Carson, MD, Brian F. Gage, MDMSc, Nicole M. Kuderer, MD, David Calverley, MD, Kristen M. Sanfilippo, MD
Journal: Blood
Blood (2016) 128 (22): 534.
https://doi.org/10.1182/blood.V128.22.534.534
Published: 2016
Journal Articles

Risk of Venous Thromboembolism in Multiple Myeloma: Identification of Risk Factor

Kristen M. Sanfilippo, MD MPHS, Natasha Catherine Edwin, MD, Brian F. Gage, MDMSc, Suhong Luo, MS, David Calverley, MD, Kenneth Carson, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4726.
https://doi.org/10.1182/blood.V128.22.4726.4726
Published: 2016